| Net income | 50.56M |
| Depreciation and amortization | 27.72M |
| Deferred tax provision | -1.93M |
| Stock option compensation | 6.86M |
| Defined benefit plan expense | |
| Loss from equity investment | |
| Loss on revaluation of financial derivatives | |
| Debt retirement expense | |
| Excess tax benefit from equity awards | |
| Accounts receivable | -22.84M |
| Inventory | -5.65M |
| Prepaid expenses and other assets | 2.83M |
| Accounts payable | 6.51M |
| Accrued liabilities | 6.12M |
| Net cash provided by operating activities | |
| Investing Activities: | |
| Purchases of short-term investments | |
| Sales of short-term investments | |
| Fund restricted cash | |
| Purchase of property and equipment | -50.74M |
| Patent costs | |
| Net cash used in investing activities | |
| Borrowing of debt | |
| Repayments of debt | |
| Cash paid for financing costs | -650K |
| Proceeds from the sale of Series C Convertible Preferred Stock | |
| Proceeds from the sale of embedded derivatives | |
| Excess tax benefit from equity awards | |
| Proceeds from the exercise of Common Stock options | 1.04M |
| Net cash provided by financing activities | |
| Foreign currency effect | |
| Net decrease in cash and cash equivalents | -11.67M |
| Cash and cash equivalents at beginning of period | 144.48M |
| Cash and cash equivalents at end of period | 132.81M |
| Cash paid for taxes | 18.18M |
| Cash paid for interest | 1.96M |
| Issuance of Common Stock under the 2006 Equity Incentive Plan | |
| Investing Activities: | |
| Purchase of business, net of cash acquired | -73.59M |
| Investing Activities: | |
| Purchase of business, net of cash acquired | |